Wnt/β-Catenin信号通路与糖尿病性骨质疏松症的研究进展

doi:10.3969/j.issn.1671-7171.2020.04.002

摘要
图/表
参考文献
相关文章 (15)

[1] Hull B, Smith NR. Diabetes and Bone[J].Am J Med Sci,2016,351(4):356-360.
[2] Retzepi M, Donos N. The effect of diabetes mellitus on osseous healing[J].Clin Oral Implants Res,2010,21(7):673-681.
[3] Kasperk C, Georgescu C, Nawroth P. Diabetes Mellitus and Bone Metabolism[J].Exp Clin Endocrinol Diabetes,2017, 125(4): 213-217.
[4] Conti F, Wolosinska DT, Pugliese G. Diabetes and bone fragility: a dangerous liaison[J].Aging Clin Exp Res,2013,25(Suppl 1):S39-S41.
[5] Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes[J].Calcif Tissue Int,2009,84(1):45-55.
[6] Joshi A,Varthakavi P,Chadha M,et al. A study of bone mineral density and its determinants in type 1 diabetes mellitus[J].J Osteoporos,2013,2013:397814.
[7] Asokan AG, Jaganathan J, Philip R, et al. Evaluation of bone mineral density among type 2 diabetes mellitus patients in South Karnataka[J].J Nat Sci Biol Med,2017,8(1):94-98.
[8] Hernandez RK, Do TP, Critchlow CW, et al. Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database[J].Acta Orthop,2012,83(6):653-660.
[9] Farr JN, Drake MT, Amin S, et al. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes[J].J Bone Miner Res,2014,29(4):787-795.
[10] Farlay D, Armas LA, Gineyts E, et al. Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone From Fractured Patients With Type 1 Diabetes Mellitus[J].J Bone Miner Res,2016,31(1):190-195.
[11] Furst JR, Bandeira LC, Fan WW, et al. Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes[J].J Clin Endocrinol Metab,2016,101(6):2502-2510.
[12] Schwartz AV, Sigurdsson S, Hue TF, et al. Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults[J].J Clin Endocrinol Metab,2013,98(6):2294-2300.
[13] Qian C, Zhu C, Yu W, et al. High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes in Rats Impacts Osteogenesis and Wnt Signaling in Bone Marrow Stromal Cells[J].PLoS One,2015,10(8):e136390.
[14] Silva JC, Sampaio P, Fernandes MH, et al. The osteogenic priming of mesenchymal stem cells is impaired in experimental diabetes[J].J Cell Biochem,2015,116(8):1658-1667.
[15] Logan CY, Nusse R. The Wnt signaling pathway in development and disease[J].Annu Rev Cell Dev Biol,2004,20(1):781-810.
[16] Huang GL, Song W, Zhou P, et al. Oncogenic retinoic acid receptor gamma knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/beta-catenin pathway[J].Cell Cycle,2017,16(7):685-692.
[17] Goto H, Kimmey SC, Row RH, et al. FGF and canonical Wnt signaling cooperate to induce paraxial mesoderm from tailbud neuromesodermal progenitors through regulation of a two-step EMT[J].Development,2017,144(8):1412-1424.
[18] Rawadi G, Vayssiere B, Dunn F, et al. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop[J].J Bone Miner Res,2003,18(10):1842-1853.
[19] Macdonald BT, Tamai K, He X. Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases[J].Dev Cell,2009,17(1):9-26.
[20] Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 Polymorphisms and progression to diabetes in the diabetes prevention program[J].N Engl J Med,2006,355(3):241-250.
[21] Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development[J].Cell,2001,107(4):513-523.
[22] Ellies DL, Viviano B, Mccarthy J, et al. Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity[J].J Bone Miner Res,2006,21(11):1738-1749.
[23] Fahiminiya S, Majewski J, Mort J, et al. Mutations in WNT1 are a cause of osteogenesis imperfecta[J].J Med Genet,2013,50(5):345-348.
[24] Ng JK, Kawakami Y, Buscher D, et al. The limb identity gene Tbx5 promotes limb initiation by interacting with Wnt2b and Fgf10[J].Development,2002,129(22):5161-5170.
[25] Barrow JR, Thomas KR, Boussadia-Zahui O, et al. Ectodermal Wnt3/beta-catenin signaling is required for the establishment and maintenance of the apical ectodermal ridge[J].Genes Dev,2003,17(3):394-409.
[26] Spater D, Hill TP, O'Sullivan RJ, et al. Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis[J].Development,2006,133(15):3039-3049.
[27] Yang Y, Topol L, Lee H, et al. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation[J].Development,2003,130(5):1003-1015.
[28] Cawthorn WP, Bree AJ, Yao Y, et al. Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism[J].Bone,2012,50(2):477-489.
[29] Friedman MS, Oyserman SM, Hankenson KD. Wnt11 promotes osteoblast maturation and mineralization through R-spondin 2[J].J Biol Chem,2009,284(21):14117-14125.
[30] Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes[J].Nat Genet,2006,38(3):320-323.
[31] Weedon MN. The importance of TCF7L2[J].Diabet Med,2007,24(10):1062-1066.
[32] Pearce NJ, Arch JRS, Clapham JC, et al. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter[J].Metabolism,2004,53(10):1322-1330.
[33] Daniele G, Winnier D, Mari A, et al. Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism[J].Diabetes Care,2015,38(8):1509-1517.